Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Ir Med J ; 116(4): 760, 2023 Apr 20.
Article in English | MEDLINE | ID: mdl-37555558
5.
J Med Microbiol ; 49(9): 779-85, 2000 Sep.
Article in English | MEDLINE | ID: mdl-10966225

ABSTRACT

Current methods for the detection of Cryptosporidium oocysts in water samples are both time-consuming and subject to variation in sensitivity. A genus-specific PCR assay was designed for the specific amplification of a 552-bp region of the 18S rRNA gene. Postamplification endonuclease restriction generated unique digest patterns that enabled differentiation between the three species, C. muris, C. baileyi and C. parvum, the major human pathogen. Theoretical restriction profiles for other Cryptosporidium species were also predicted. The assay routinely detected 10 oocysts in 10-ml purified oocyst preparations, but sensitivity was found to be 10(3)-10(4) -fold lower in environmental water samples. The use of Chelex resin and an immunomagnetic separation procedure overcame this inhibition. This provided detection levels of 10(1)-10(3) oocysts, depending on water turbidity. Rapid and sensitive pathogen detection methods are essential for the water industry. The results of this study demonstrate that PCR has the potential to improve current detection capabilities greatly by differentiating the major human pathogens from non-pathogenic species. This will greatly facilitate a closer examination of the epidemiology of this important pathogen.


Subject(s)
Cryptosporidium/isolation & purification , Immunomagnetic Separation/methods , Polymerase Chain Reaction/methods , Water/parasitology , Animals , Cryptosporidiosis/parasitology , Cryptosporidium/classification , Cryptosporidium/genetics , Cryptosporidium parvum/classification , Cryptosporidium parvum/genetics , Cryptosporidium parvum/isolation & purification , DNA Restriction Enzymes/metabolism , DNA, Ribosomal/isolation & purification , Humans , RNA, Ribosomal, 18S/genetics , Sensitivity and Specificity
6.
J Hypertens ; 16(1): 103-9, 1998 Jan.
Article in English | MEDLINE | ID: mdl-9533423

ABSTRACT

OBJECTIVE: To determine whether combination of an angiotensin converting enzyme inhibitor with a high dose of thiazide diuretic avoids adverse metabolic consequences of thiazide diuretics. DESIGN: Double-blind randomized crossover study of two 12-week treatment periods with captopril (up to 100 mg/day) either alone or in combination with 5 mg bendrofluazide given after a 6-week placebo run-in period. Treatment periods were separated by a 6-week placebo washout period. SETTING: Outpatient clinics in greater Belfast. PATIENTS: Fifteen white non-diabetic essential hypertensives (seven male) aged < 65 years recruited from general practices in greater Belfast. MAIN OUTCOME MEASURES: Systolic and diastolic blood pressures and peripheral and hepatic insulin action. RESULTS: Two patients failed to complete the study. Blood pressure was lowered (139/89+/-18/7 mmHg combination versus 160/97+/-21/7 mmHg captopril; P < 0.001). Fasting insulin level was raised (7.9+/-3.6 mU/l combination versus 6.2+/-3.2 mU/l baseline; P < 0.001). There were no differences between treatments for glucose, urate, cholesterol and triglyceride levels. Serum potassium level was lowered (3.8+/-0.4 mmol/l combination versus 4.2+/-0.4 mmol/l captopril, P < 0.05). Postabsorptive endogenous glucose production was raised (10.8+/-1.7 micromol/kg per min combination versus 10.0+/-1.5 micromol/kg per min captopril; P < 0.01) and was greater than baseline (9.7+/-2.1 micromol/kg per min, P < 0.05). Suppression of glucose production by insulin was similar with both treatments. Exogenous glucose infusion rates required to maintain euglycaemia did not differ (32.4+/-7.6 micromol/kg per min captopril, 32.7+/-6.2 micromol/kg per min combination, 31.5+/-7.2 micromol/kg per min baseline). CONCLUSIONS: Combination therapy increased glucose production (compared with captopril alone), indicating hepatic insulin resistance. It cannot be assumed that combined preparations with angiotensin converting enzyme inhibitors will ameliorate adverse effects of high doses of thiazide diuretics on insulin action.


Subject(s)
Angiotensin-Converting Enzyme Inhibitors/administration & dosage , Antihypertensive Agents/administration & dosage , Bendroflumethiazide/administration & dosage , Captopril/administration & dosage , Hypertension/drug therapy , Hypertension/metabolism , Insulin Resistance , Sodium Chloride Symporter Inhibitors/administration & dosage , Antihypertensive Agents/adverse effects , Bendroflumethiazide/adverse effects , Blood Pressure/drug effects , Cross-Over Studies , Diuretics , Double-Blind Method , Drug Therapy, Combination , Female , Glucose Clamp Technique , Humans , Hypertension/physiopathology , Liver/metabolism , Male , Middle Aged , Sodium Chloride Symporter Inhibitors/adverse effects
7.
J Clin Pathol ; 45(8): 738-40, 1992 Aug.
Article in English | MEDLINE | ID: mdl-1401193

ABSTRACT

A method of specimen turnround time audit, directly controlled by laboratory staff, was applied to a bacteriology service to assess service efficiency and identify delays and other deficiencies, so that resources could be optimised. The method provided a complete collection of turnround time data and was easy to use. Delays of both administrative and technical natures were identified, and with minimal reorganisation the mean turnround time was improved.


Subject(s)
Bacteriology , Laboratories, Hospital , Medical Audit , Time Factors
8.
J Infect ; 16(3): 235-42, 1988 May.
Article in English | MEDLINE | ID: mdl-3397578

ABSTRACT

Altogether, 488 consecutive strains of Streptococcus pneumoniae isolated from clinical specimens were serotyped and their antibiotic susceptibility determined. Of all strains isolated, 89.7% (90.6% for strains isolated from patients with serious infection) were of types present in the new polyvalent (23-valent) pneumococcal vaccine. Four strains showed reduced susceptibility to penicillin (minimum inhibitory concentration 0.1-1.0 mg/l). Two of those strains (both serotype 23) were also of intermediate susceptibility to other antibiotics (ampicillin, cephradine, chloramphenicol and tetracycline) but were sensitive to erythromycin. A significant proportion (12%) was resistant to tetracycline.


Subject(s)
Pneumococcal Infections/microbiology , Streptococcus pneumoniae/classification , Agglutination Tests , Ampicillin/pharmacology , Cephradine/pharmacology , Chloramphenicol/pharmacology , Counterimmunoelectrophoresis , Drug Resistance, Microbial , Erythromycin/pharmacology , Humans , Latex Fixation Tests , Northern Ireland , Penicillins/pharmacology , Serotyping , Streptococcus pneumoniae/drug effects , Tetracycline/pharmacology
10.
J Clin Endocrinol Metab ; 60(2): 328-32, 1985 Feb.
Article in English | MEDLINE | ID: mdl-2981244

ABSTRACT

A 71-yr-old woman with clinical signs of Cushing's syndrome was studied continuously for an extended period after demonstration of a paradoxical response to dexamethasone. She proved to have a corticotroph cell adenoma of the pituitary which caused secretion of ACTH and cortisol in two distinct rhythms. One rhythm consisted of a period of 40 days of excess cortisol production, followed by a period of 60-70 days of normal production. During the period of excess cortisol production there was a second rhythm, consisting of peaks of cortisol production every 3-6 days with intervening troughs of normal cortisol production. Prolonged clinical remission followed transphenoidal surgery, but the pituitary still has the ability to provoke abnormal amounts of cortisol secretion, as occurred during a postoperative dexamethasone suppression test. The long duration of normal cortisol production phases in this patient demonstrates the difficulty in excluding Cushing's syndrome in patients with suggestive clinical symptoms but normal serum and urinary cortisol levels if these tests are measured for a single short phase of several days.


Subject(s)
Adenoma, Basophil/metabolism , Cushing Syndrome/metabolism , Hydrocortisone/metabolism , Pituitary Neoplasms/metabolism , Adenoma, Basophil/complications , Adrenocorticotropic Hormone/metabolism , Aged , Cushing Syndrome/etiology , Dexamethasone/administration & dosage , Female , Humans , Hydrocortisone/biosynthesis , Hypophysectomy , Periodicity , Pituitary Neoplasms/complications
SELECTION OF CITATIONS
SEARCH DETAIL
...